Literature DB >> 6752115

Characterization of eight beta-lactamases of Gram-negative bacteria.

T Sawai, M Kanno, K Tsukamoto.   

Abstract

Eight kinds of beta-lactamases produced by gram-negative bacteria were characterized by the following properties: molecular weight, isoelectric point, pH optimum, molecular activity, immunochemical reactivity, and kinetic parameters with respect to twelve kinds of common beta-lactam antibiotics. These beta-lactamases included two types of penicillinases mediated by R plasmids and six kinds of species-specific cephalosporinases. To determine a reliable value of the kinetic parameter, Km, we introduced a continuous and acidimetric assay method of beta-lactamase activity with a pH stat.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752115      PMCID: PMC221503          DOI: 10.1128/jb.152.2.567-571.1982

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  22 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Disk electrophoresis of basic proteins and peptides on polyacrylamide gels.

Authors:  R A REISFELD; U J LEWIS; D E WILLIAMS
Journal:  Nature       Date:  1962-07-21       Impact factor: 49.962

3.  Micro-iodometric assay for penicillinase.

Authors:  R P NOVICK
Journal:  Biochem J       Date:  1962-05       Impact factor: 3.857

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Inhibition of beta-lactamase of Bacillus licheniformis 749/C by compound PS-5, a new beta-lactam antibiotic.

Authors:  Y Fukagawa; T Takei; T Ishikura
Journal:  Biochem J       Date:  1980-01-01       Impact factor: 3.857

6.  A set of bacterial strains for evaluation of beta-lactamase-stability of beta-lactam antibiotics.

Authors:  T Sawai; T Yoshida; K Tsukamoto; S Yamagishi
Journal:  J Antibiot (Tokyo)       Date:  1981-10       Impact factor: 2.649

7.  Purification and some properties of a cephalosporinase from Proteus vulgaris.

Authors:  N Matsubara; A Yotsuji; K Kumano; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

8.  A simple method for testing the efficacy of a beta-lactamase inhibitor against beta-lactamase-producing gram-negative bacteria.

Authors:  T Sawai; T Yoshida
Journal:  J Antibiot (Tokyo)       Date:  1982-08       Impact factor: 2.649

9.  Iodometric assay method for beta-lactamase with various beta-lactam antibiotics as substrates.

Authors:  T Sawai; I Takahashi; S Yamagishi
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

10.  Cefoxitin resistance by a chromosomal cephalosporinase in Escherichia coli.

Authors:  I Takahashi; T Sawai; T Ando; S Yamagishi
Journal:  J Antibiot (Tokyo)       Date:  1980-09       Impact factor: 2.649

View more
  19 in total

1.  In vitro investigation of BK-218, a new oral and parenteral cephalosporin.

Authors:  I Szabó; J Barabás; A Tar; L Kiss; M Filep; T Schmidt; K Marossy; B Tóth-Martinez; G Barabás; F Hernádi
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

Review 2.  Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

3.  Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers.

Authors:  Corinne Arpin; Laure Coulange; Véronique Dubois; Catherine André; Isabelle Fischer; Sophie Fourmaux; Frédéric Grobost; Jacqueline Jullin; Brigitte Dutilh; Jean-Francois Couture; Patrick Noury; Isabelle Lagrange; Aline Ducastaing; Henri-Pierre Doermann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2007-06-25       Impact factor: 5.191

4.  In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.

Authors:  M D Kitzis; B Ferré; A Coutrot; J F Acar; L Gutmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

5.  Extension of the substrate spectrum by an amino acid substitution at residue 219 in the Citrobacter freundii cephalosporinase.

Authors:  K Tsukamoto; R Ohno; T Sawai
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

6.  Development of a sensitive and specific enzyme-linked immunosorbent assay for detecting and quantifying CMY-2 and SHV beta-lactamases.

Authors:  Andrea M Hujer; Malcolm G P Page; Marion S Helfand; Bethany Yeiser; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 7.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

8.  Purification and characterization of two kinds of porins from the Enterobacter cloacae outer membrane.

Authors:  M Kaneko; A Yamaguchi; T Sawai
Journal:  J Bacteriol       Date:  1984-06       Impact factor: 3.490

9.  Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation.

Authors:  A Yamaguchi; T Hirata; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

10.  Interaction of oxyimino beta-lactams with a class C beta-lactamase and a mutant with a spectrum extended to beta-lactams.

Authors:  M Nukaga; K Tsukamoto; H Yamaguchi; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.